(SLGN) Silgan Holdings - Ratings and Ratios
Dispensing Closures, Metal Containers, Custom Plastic, Thermoformed Trays
SLGN EPS (Earnings per Share)
SLGN Revenue
Description: SLGN Silgan Holdings November 05, 2025
Silgan Holdings Inc. (NYSE: SLGN) manufactures rigid packaging for consumer goods, operating in the United States and abroad through three business segments: Dispensing & Specialty Closures, Metal Containers, and Custom Containers.
The Dispensing & Specialty Closures segment supplies proprietary metal and plastic closures, capping equipment, and fragrance-detection systems for markets such as beauty, food, beverage, and health care. The Metal Containers segment produces steel and aluminum cans for food processors (e.g., pet food, soups, proteins) and general-line promotional cans. The Custom Containers segment offers high-density polyethylene (HDPE) and PET containers, thermo-formed bowls, and trays for shelf-stable foods, as well as plastic caps and fitments.
Silgan reaches customers primarily via a direct sales force, a network of distributors, and an online catalog, leveraging its integrated packaging solutions to lock in multi-product contracts with major CPG manufacturers.
Key performance indicators from the most recent fiscal year show revenue of approximately $2.1 billion, an adjusted EBITDA margin near 8 %, and a capital-intensity ratio of 0.45, indicating moderate leverage. The business is sensitive to aluminum and steel price volatility, which have risen 12 % year-over-year, and to consumer-packaged-goods demand trends-particularly the continued shift toward single-serve and on-the-go formats that boost closure and metal-can volumes.
For a deeper, data-driven assessment of Silgan’s valuation dynamics and scenario analysis, you may find the analytics on ValueRay worth exploring.
SLGN Stock Overview
| Market Cap in USD | 4,094m |
| Sub-Industry | Metal, Glass & Plastic Containers |
| IPO / Inception | 1997-02-13 |
SLGN Stock Ratings
| Growth Rating | -24.9% |
| Fundamental | 59.1% |
| Dividend Rating | 58.5% |
| Return 12m vs S&P 500 | -36.4% |
| Analyst Rating | 4.42 of 5 |
SLGN Dividends
| Dividend Yield 12m | 2.07% |
| Yield on Cost 5y | 2.48% |
| Annual Growth 5y | 12.17% |
| Payout Consistency | 63.5% |
| Payout Ratio | 23.9% |
SLGN Growth Ratios
| Growth Correlation 3m | -74.1% |
| Growth Correlation 12m | -54.5% |
| Growth Correlation 5y | 74.3% |
| CAGR 5y | -6.63% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.20 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.55 |
| Sharpe Ratio 12m | -0.32 |
| Alpha | -40.48 |
| Beta | 0.689 |
| Volatility | 24.92% |
| Current Volume | 1322.8k |
| Average Volume 20d | 1064k |
| Stop Loss | 36.9 (-3.4%) |
| Signal | -0.40 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (1.95b TTM) > 0 and > 6% of Revenue (6% = 1.12b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -6.25pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.70% (prev 2.44%; Δ 6.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 343.9m <= Net Income 1.95b (YES >=105%, WARN >=100%) |
| Net Debt (3.99b) to EBITDA (857.8m) ratio: 4.66 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (107.3m) change vs 12m ago 0.27% (target <= -2.0% for YES) |
| Gross Margin 72.84% (prev 16.84%; Δ 56.00pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 217.9% (prev 75.93%; Δ 142.0pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.14 (EBITDA TTM 857.8m / Interest Expense TTM 178.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.27
| (A) 0.17 = (Total Current Assets 2.82b - Total Current Liabilities 1.20b) / Total Assets 9.41b |
| (B) 0.37 = Retained Earnings (Balance) 3.52b / Total Assets 9.41b |
| (C) 0.07 = EBIT TTM 558.5m / Avg Total Assets 8.55b |
| (D) 0.46 = Book Value of Equity 3.28b / Total Liabilities 7.19b |
| Total Rating: 3.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.05
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 0.70% = 0.35 |
| 3. FCF Margin 0.31% = 0.08 |
| 4. Debt/Equity 1.94 = 0.86 |
| 5. Debt/Ebitda 4.66 = -2.50 |
| 6. ROIC - WACC (= 3.76)% = 4.70 |
| 7. RoE 93.57% = 2.50 |
| 8. Rev. Trend 41.91% = 3.14 |
| 9. EPS Trend 8.31% = 0.42 |
What is the price of SLGN shares?
Over the past week, the price has changed by -1.09%, over one month by -11.25%, over three months by -17.70% and over the past year by -27.51%.
Is Silgan Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SLGN is around 30.88 USD . This means that SLGN is currently overvalued and has a potential downside of -19.16%.
Is SLGN a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the SLGN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.4 | 31.9% |
| Analysts Target Price | 50.4 | 31.9% |
| ValueRay Target Price | 33.3 | -12.9% |
SLGN Fundamental Data Overview November 01, 2025
P/E Trailing = 13.0136
P/E Forward = 9.8135
P/S = 0.6371
P/B = 2.052
P/EG = 0.8384
Beta = 0.689
Revenue TTM = 18.63b USD
EBIT TTM = 558.5m USD
EBITDA TTM = 857.8m USD
Long Term Debt = 3.11b USD (from longTermDebt, last quarter)
Short Term Debt = 1.20b USD (from shortTermDebt, last quarter)
Debt = 4.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.99b USD (from netDebt column, last quarter)
Enterprise Value = 8.09b USD (4.09b + Debt 4.31b - CCE 317.5m)
Interest Coverage Ratio = 3.14 (Ebit TTM 558.5m / Interest Expense TTM 178.0m)
FCF Yield = 0.70% (FCF TTM 56.9m / Enterprise Value 8.09b)
FCF Margin = 0.31% (FCF TTM 56.9m / Revenue TTM 18.63b)
Net Margin = 10.48% (Net Income TTM 1.95b / Revenue TTM 18.63b)
Gross Margin = 72.84% ((Revenue TTM 18.63b - Cost of Revenue TTM 5.06b) / Revenue TTM)
Gross Margin QoQ = 91.15% (prev 18.44%)
Tobins Q-Ratio = 0.86 (Enterprise Value 8.09b / Total Assets 9.41b)
Interest Expense / Debt = 1.13% (Interest Expense 48.7m / Debt 4.31b)
Taxrate = 1.20% (30.5m / 2.54b)
NOPAT = 551.8m (EBIT 558.5m * (1 - 1.20%))
Current Ratio = 2.35 (Total Current Assets 2.82b / Total Current Liabilities 1.20b)
Debt / Equity = 1.94 (Debt 4.31b / totalStockholderEquity, last quarter 2.22b)
Debt / EBITDA = 4.66 (Net Debt 3.99b / EBITDA 857.8m)
Debt / FCF = 70.24 (Net Debt 3.99b / FCF TTM 56.9m)
Total Stockholder Equity = 2.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.75% (Net Income 1.95b / Total Assets 9.41b)
RoE = 93.57% (Net Income TTM 1.95b / Total Stockholder Equity 2.09b)
RoCE = 10.74% (EBIT 558.5m / Capital Employed (Equity 2.09b + L.T.Debt 3.11b))
RoIC = 8.50% (NOPAT 551.8m / Invested Capital 6.49b)
WACC = 4.74% (E(4.09b)/V(8.41b) * Re(8.55%) + D(4.31b)/V(8.41b) * Rd(1.13%) * (1-Tc(0.01)))
Discount Rate = 8.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.19%
[DCF Debug] Terminal Value 75.55% ; FCFE base≈245.1m ; Y1≈231.6m ; Y5≈219.5m
Fair Price DCF = 33.43 (DCF Value 3.58b / Shares Outstanding 107.0m; 5y FCF grow -7.10% → 3.0% )
EPS Correlation: 8.31 | EPS CAGR: 8.83% | SUE: -0.36 | # QB: 0
Revenue Correlation: 41.91 | Revenue CAGR: 104.1% | SUE: 4.0 | # QB: 1
Additional Sources for SLGN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle